AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 145 filers reported holding AMNEAL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $656,683 | +73.7% | 155,612 | +27.6% | 0.00% | – |
| Q2 2023 | $378,157 | +12.0% | 121,986 | -49.8% | 0.00% | – |
| Q1 2023 | $337,578 | +37.4% | 242,862 | +96.7% | 0.00% | – |
| Q4 2022 | $245,739 | -0.9% | 123,487 | +0.5% | 0.00% | – |
| Q3 2022 | $248,000 | -37.2% | 122,829 | -1.1% | 0.00% | – |
| Q2 2022 | $395,000 | -23.7% | 124,245 | -0.0% | 0.00% | – |
| Q1 2022 | $518,000 | – | 124,253 | +161267.5% | 0.00% | – |
| Q2 2020 | $0 | – | 77 | -22.2% | 0.00% | – |
| Q1 2020 | $0 | – | 99 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | – | 99 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 99 | -100.0% | 0.00% | -100.0% |
| Q2 2019 | $72,109,000 | -30.2% | 10,056,968 | +37.9% | 0.01% | -33.3% |
| Q1 2019 | $103,373,000 | +4.5% | 7,295,225 | -0.2% | 0.01% | -14.3% |
| Q4 2018 | $98,912,000 | -55.6% | 7,310,555 | -27.2% | 0.01% | -44.0% |
| Q3 2018 | $222,767,000 | +70.9% | 10,039,109 | +26.4% | 0.02% | +66.7% |
| Q2 2018 | $130,351,000 | – | 7,943,403 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 21,521,301 | $90,819,890 | 14.58% |
| Eversept Partners, LP | 2,644,988 | $11,161,849 | 0.94% |
| TPG GP A, LLC | 12,328,767 | $52,027,397 | 0.90% |
| Nantahala Capital Management | 2,212,757 | $9,337,835 | 0.80% |
| Rubric Capital Management LP | 4,024,500 | $16,983,390 | 0.64% |
| Hedges Asset Management LLC | 84,600 | $357,012 | 0.31% |
| Signature Wealth Management Partners, LLC | 66,666 | $281,331 | 0.28% |
| Tejara Capital Ltd | 96,672 | $407,956 | 0.23% |
| Tranquilli Financial Advisor LLC | 71,414 | $301,367 | 0.22% |
| EAM Investors, LLC | 230,271 | $971,744 | 0.19% |